Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Gynecol Oncol. 2016 Oct 12;143(3):460–465. doi: 10.1016/j.ygyno.2016.10.016

Fig. 1.

Fig. 1

a: Kaplan–Meier curves of progression-free survival for all patients, stratified by histology group. Figures below months indicate the numbers of patients at risk. The p-value is from the Wald test to compare hazard ratios between the histology subgroups in the multivariate model. Legend: endo: grade 3 endometrioid; other: USC, CCC and carcinosarcoma. b: Kaplan–Meier curves of overall survival for all patients, stratified by histology group. Figures below months indicate the numbers of patients at risk. The p-value is from the Wald test to compare hazard ratios between the histology subgroups in the multivariate model. Legend: endo: grade 3 endometrioid; other: USC, CCC and carcinosarcoma.